Results 181 to 187 of about 939 (187)

Ubrogepant alleviates migraine premonitory symptoms

Nature Reviews Neurology
openaire   +2 more sources

Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.

The Journal of family practice, 2020
David W, Dodick, Jessica, Ailani
openaire   +1 more source

LC-HRMS and NMR Studies for the Characterization of Degradation Impurities of Ubrogepant Along With the in Silico Approaches for the Prediction of Degradation and Toxicity

Journal of Pharmaceutical and Biomedical Analysis
Gananadhamu Samanthula, Vijaya Madhyanapu Golla, Pushpa Pilli   +2 more
exaly  

Lasmiditan (Reyvow) and ubrogepant (Ubrelvy) for acute treatment of migraine.

The Medical letter on drugs and therapeutics, 2020
openaire   +1 more source

Evaluating Ubrogepant-Related Adverse Events Using the FDA Adverse Event Reporting System

Expert Opinion on Drug Safety
Zhisen Shen, Hang Chen
exaly  

Efficacy and Safety of Ubrogepant for Migraine: A Meta-Analysis of Randomized Controlled Studies

International Journal of Neuroscience
exaly  

PHARMACEUTICAL COMPOSITION COMPRISING UBROGEPANT AND ADMINISTRATION THEREOF

THAKKALAPALLY LAKSHMI RAO, MATLAPUDI MEGHA SHYAM, MOHAN VIGNESH, SAMETHANAHALLI BASAPPA CHANDRA MOHAN, KAWDE AKSHAY BHAGWAN   +4 more
openaire   +1 more source